Scholars Central

Conference abstractPublished 20 Jul 2015

Plant biopolymers from Boraginaceae family species and their synthetic derivatives: Prospective pharmacological agents

Authors: K Mulkijanyan

Tbilisi State Medical University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Extracts from the plants belonging to Boraginaceae family – Symphytum asperum, S.caucasicum and Anchusa italica have been used in folk medicine in the treatment of some kinds of disorders, mainly fractures and wounds. These extracts contain allantoin, claimed to be a cell proliferation-stimulating agent responsible for the wound-healing properties of Symphytum, and, on the other hand, hepatotoxic pyrrolizidine alkaloids, which strongly restrict internal use of comfrey extracts. Our research group succeeded in obtaining allantoin- and toxic pyrrolizidine alkaloids-free composition containing novel biopolymer from the roots of aforesaid plants – poly[oxy-1-carboxy-2-(3,4-dihydroxyphenyl)ethylene] (BP) and synthesis of its monomer (M-BP). BP and M-BP were studied to appraise their pharmacological properties. Different in vitro and in vivo experiments revealed that the investigated compounds exhibit: i) antioxidant activity and anticomplementary activity due to the inhibition of xantine oxidase and complement convertase, respectively; ii) burn and wound healing properties due to the shortening of the second phase of wound healing - the inflammatory response; iii) inhibition of androgen-dependent and -independent prostate cancer (PCA) cells growth in vitro. Consistent with in vitro results, in vivo study showed that BP strongly inhibited 22Rvl tumors growth without any toxicity; iv) abrogation of melanoma cells adhesion to tumor-conditioned medium- and VEGF-activated endothelial cells; v) significant stimulation of leucopoiesis in mice drug-induced leukopenia. Strong efficacy of BP and M-BP in different experimental models suggests its high therapeutic potential.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “K Mulkijanyan”